Theravance Biopharma Stock
Your prediction
Theravance Biopharma Stock
We can see a decrease in the price for Theravance Biopharma. Compared to yesterday it has lost -€0.300 (-1.910%).
Pros and Cons of Theravance Biopharma in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Theravance Biopharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1.910% | -0.633% | -1.875% | 74.444% | - | 52.427% | 11.348% |
| Rockwell Medical Inc. | 7.390% | -4.111% | -19.893% | -69.826% | - | -29.162% | -92.500% |
| Pacira Pharmaceuticals | -4.630% | 0.000% | 6.931% | 22.034% | - | -40.984% | -54.237% |
| Twist Bioscience Corp | 1.270% | -3.726% | -1.846% | -39.747% | -0.718% | 15.425% | -74.633% |
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue